“implantable biomaterials global market – forecast to 2022”

IQ4I Research & Consultancy Pvt. Ltd.

Implantable Biomaterials Global Market

–Forecast to 2022

Implantable Biomaterials Global Market estimated to be worth $21,124.2 million by 2022 IQ4I Research & Consultancy published a new report on “Implantable Biomaterials

Global Market – Forecast To 2022” This report analyzes and studies the overall market,

major drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific

and Rest of the World

IQ4I’s Report Contains 220 market data tables and 81 figures spread through 497

pages and an exhaustive TOC on “Implantable Biomaterials Global Market [Type (Metal and Metal alloys (Titanium & its Alloys, Cobalt-Chrome, Stainless Steel, Magnesium & Alloys and others), Synthetic Polymers (Polyetheretherketone (PEEK), Polytetrafluoroethylene (PTFE), Polyethylene terephthalate (PETE), Polyethylene / Ultra High Molecular Weight Polyethylene (UHMWPE), Polymethylmethacrylate (PMMA), Polyurethanes, Silicone, Resorbable polymers, Hydrogels and others); Ceramic Biomaterials (Calcium compositions, Aluminium oxide, Zirconia, Carbon, Glass and Silicon nitride); Natural biomaterials (Cellulose, Collagen & Gelatin, Hyaluronic Acid / Hyaluronan, Fibrin, Chitin / Chitosan, Elastin, Silk, and Others) and Composites; APPLICATIONS (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Ophthalmology, Neurology and other Applications.); REGION (North America (United States and Others), Europe (Germany, U.K., France and Others), Asia-Pacific (Japan, China, India and Others) and Rest of the World (Latin America, Middle East and Others)]

This report analyzes the Implantable Biomaterials global market in terms of market revenue

($ million) for all segments and it enables Implantable Biomaterials global market

stakeholders such as device manufacturers, distributors and wholesalers, OEM (Original

Equipment Manufacturers)/contract manufacturers, hospitals and various academic research

institutes to identify and analyze market expansion opportunities, upcoming technologies

and competition in Implantable Biomaterials global market.

A biomaterial is a substance intended to interface with biological systems to evaluate, treat,

augment, or replace any tissue, organ, or function of the body for a life time, such as total hip

replacements, as well as those that interact with the body for short periods of time, such as

soft contact lenses. The source of biomaterials can be derived from natural or synthetic by

variety of processes laboratory using metallic, ceramic, polymer, natural and composite raw

materials. The selection of biomaterial is dependent on the application and properties of

materials. Biomaterials are used to develop and manufacture implantable medical devices

and grafts in many medical conditions. As estimated by IQ4I Research, implantable



–Forecast to 2022

biomaterials global market is expected to grow at a strong CAGR to reach $21,124.2 million

by 2022.

The increasing aging population, increasing demand for minimally invasive procedures,

increasing research and development investments, growing demand for plastic surgery,

miniaturization of implant devices, advance technologies and reimbursements are the factors

driving the biomaterials global market. However, limitations of biomaterial based products,

stringent regulations posed on biomaterial based products, complications due to implant

rejection, cytotoxicity, and corrosion of biomaterials implant are restraining the growth of

biomaterials global market.

Advancements and newer technologies like 3D printing are revolutionizing implantable

biomaterials market. 3D Printing promises to produce complex biomedical devices using

computer design based on patient-specific anatomical data. Before 3D Printing can be used

routinely for the regeneration of complex tissues (e.g. bone, cartilage, muscles, vessels,

nerves in the craniomaxillofacial complex), and complex organs with intricate 3D

microarchitecture (e.g. liver, lymphoid organs). The commonly used 3D printing technologies

are Fused Deposition Modeling, Selective Laser Sintering, Stereolithography, and 3D

Plotting/Direct-Write/ Bioprinting. With the increase in 3D printing technology better and

anatomically accurate implants can be manufactured which directly affects the consumption

of biomaterials by medical implants manufacturing companies.

A leading advanced materials and 3D printing company, Oxford Performance Materials,

Inc. (OPM), has announced that it has received 510(k) clearance from the US Food & Drug

Administration (FDA) for its 3D printed OsteoFab Patient-Specific Facial Device. Currently, it

is the only cleared 3D printed polymeric implant for facial indications of its kind, although it is

not completely new territory for OPM as the company previously got FDA clearance for

another kind of 3D printed medical implant in February 2013.

Amedica Corporation is the first company to create medical silicon nitride ceramics using a

3D printing process called robotic deposition, or robocasting. The 3D printed products have

been shown to possess similar properties to traditionally manufactured alternatives.

In February 2016 BioArchitects received 510(k) clearance by the U.S. Food and Drug

Administration – FDA, for the company’s 3D printed patient specific titanium

cranial/craniofacial plate implant. Designed for the repair of defects in the non-loadbearing

http://www.amedica.com/



–Forecast to 2022

bones of the head and face, each custom designed plate is permanently attached to the

skull and/or face with self-tapping titanium screws.

The implantable biomaterials global market is segmented based on type, application, and

geography. The market by type is divided into Metallic biomaterials, Synthetic polymers,

Ceramic biomaterials, Natural biomaterials and Composite biomaterials. The implantable

biomaterials application is further sub-segmented into Cardiovascular, Orthopedic, Dental,

Plastic Surgery, Wound Healing, Ophthalmology, Neurology and Other Applications. The

Orthopedic occupied highest market in implantable biomaterials application market.

Geographically, North American regions held the largest market share and U.S. dominates

the North American region with market share of 79.2% and expected to show a CAGR due

to the high advanced healthcare facilities, increasing ageing population, increased growing

awareness about the technological advancements, availability of Medicare and third party

insurance facilities, easy availability of skilled personnel are driving the market growth. In

Asia-Pacific region Japan dominates the biomaterials market with share of 30.7% and

expected to grow at a strong CAGR due to high levels of healthcare expenditure and a

massive elderly population, technological advancements and reimbursement by Japan’s

National Health Insurance (NHI) system are the major factors contributing the biomaterials

market in Japan. Japan has world’s largest and fastest rates of aging population in the world

which results in high rates of orthopedic, dental, ophthalmology and cardiovascular

disorders. In Rest of the World regions Latin America countries especially Brazil dominates

the implantable biomaterials market with share of 50.7% and is expected to grow at the

strong rate due to The growth in this market is mainly due to the high acceptance of

technological advancements, Medicare facilities, sophisticated infrastructure related to

healthcare and high expenditure and mainly the easy availability of skilled personnel and

treatment style has led the Brazil as the dominant region of biomaterials market.

Some of the prominent players in implantable biomaterials market include Solvay Advanced

Polymers, LLC (Belgium), Evonik Industries AG (Germany), Carpenter Technology

Corporation (U.S.), Royal DSM (Netherlands), Johnson Matthey Plc (U.K.), Morgan

Advanced Materials plc (U.K.), Materion (U.S.), Victrex PLC (Invibio Biomaterial Solutions )

(U.K.) and Collagen solutions (U.K.), Corbion N.V. (Netherlands), Landec Corporation (U.S.).

Reasons for buying this report:



–Forecast to 2022

Analysis of the implantable biomaterials global market by identifying various

segments by type, source, application, and geography.

Revenue forecast of the implantable biomaterials market and strategic analysis of

each submarket with respect to segmental growth trends.

Analysis of the major market trends and factors driving or inhibiting the growth of the

implantable biomaterials global market.

Revenue forecast of the healthcare analytics market with respect to North America,

Europe, Asia-Pacific and the Rest of the World (RoW) regions.

Analysis of the opportunities for stakeholders by identifying the high-growth

segments of the market.

Regional market share analysis of implantable biomaterials by major players.

Market share analysis of key players in implantable biomaterials, details of their

product offerings, revenues, business strategies and SWOTs.

Established and Emerging players (86 companies) and their product offerings.



–Forecast to 2022

FIGURE 1

IMPLANTABLE BIOMATERIALS GLOBAL MARKET SEGMENTATION


Metallic

Biomaterials

By Application By Region

Synthetic

Polymers Cardiovascular NA

U.S.

Others

EU

Germany, France,

U.K., Others

By Type

Orthopedic

Dental

Plastic surgery

Wound healing

Ophthalmology

Neurology

Others

Ceramic

Biomaterials

Natural

BiomaterialsComposites

APAC

Japan, China,

India, Others

RoW

Latin America,

Middle East, Others

Titanium &

alloys

Stainless

Steel

Magnesium

& alloys

Others

Cobalt-

Chrome

PEEK

PETE

UHMWPE

PMMA

Hydrogel

Resorbable

Polymers

Silicone

PTFE

PU

Others

Carbon

Zirconia

Aluminium

oxide

Calcium

composition

Glass

Silicon

nitride

Cellulose

Hyaluronan

Fibrin

Chitin

Others

Silk

Collagen

Elastin

“implantable biomaterials global market – forecast to 2022”

Healthcare